Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

BioMarin Pharmaceutical Inc. buy Barclays PLC

BioMarin Pharmaceutical Inc.
Start price
€47.65
28.01.26 / 50%
Target price
€66.71
28.01.27
Performance (%)
3.15%
Price
€49.15
02.02.26
Summary
This prediction is currently active. The BUY prediction by Barclays_PLC shows slight gains of 3.15%. This prediction currently runs until 28.01.27. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this prediction
Performance without dividends (%)
Name 1w
BioMarin Pharmaceutical Inc. 3.15%
iShares Core DAX® -0.436%
iShares Nasdaq 100 0.854%
iShares Nikkei 225® 2.652%
iShares S&P 500 1.190%

Comments by Barclays_PLC for this prediction

In the thread BioMarin Pharmaceutical Inc. diskutieren
Prediction Buy
Perf. (%) 3.15%
Target price 66.712
Change
Ends at 28.01.27

BioMarin Pharmaceutical (NASDAQ:BMRN) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $80.00 price target on the stock.
Ratings data for BMRN provided by MarketBeat

Barclays PLC 
0
Report Share
28.01.26

Stopped prediction by Barclays_PLC for BioMarin Pharmaceutical Inc.

buy
BioMarin Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€46.90
28.10.25
€68.62
28.10.26
4.80%
02.02.26

Barclays PLC 
28.10.25 50%
buy
BioMarin Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€62.80
04.10.24
€78.35
04.10.25
-24.70%
05.10.25

Barclays PLC 
04.10.24 50%
buy
BioMarin Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€79.46
06.08.24
€100.74
06.08.25
-34.76%
07.08.25

Barclays PLC 
06.08.24 50%